Below, we review the existing research so you can weigh the pros and cons with your healthcare provider
Understanding the differences between their mechanisms, half-lives, and dosing protocols will determine whether your switch is smooth or rocky
For AD specifically, given the well-established effects of GLP-1 RAs on tau hyperphosphorylation, we recommend that future GLP-1 RA clinical trials focus on the tau-positive subgroup of patients
These messages make a difference in our work on Capitol Hill
Addressing all of these together produces the most significant improvement in energy levels
The blend leverages the multi-receptor activation of GLP3 with the satiety-enhancing and gastric-slowing effects of cagrilintide, providing researchers with a comprehensive approach to investigating appetite control, energy expenditure, and glucose metabolism